{
    "nct_id": "NCT03391778",
    "official_title": "Long-Term Follow-Up (LTFU) of Participants Treated With ADP Adoptive Cell Therapies",
    "inclusion_criteria": "* Participants who have received at least one dose of ADP adoptive cell therapy agent.\n* Participants who have completed ADP sponsored or supported interventional study or have withdrawn from it.\n* Participants who have completed treatment as part of managed access to a GSK adoptive cell therapy.\n* Contraceptive use by men or women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies.\n* The investigator is responsible for review of medical history.\n* Capable of giving signed informed consent.\nHealthy volunteers allowed",
    "exclusion_criteria": "- None",
    "miscellaneous_criteria": ""
}